secwatch / observer
8-K filed June 12, 2026, 8:00 AM ET ticker BCDA CIK 0000925741
regulatory confidence high sentiment positive materiality 0.70

BioCardia, Inc. (BCDA): Nasdaq/NYSE listing notice — BioCardia regains Nasdaq minimum equity compliance after $4.9M ATM raise

BioCardia, Inc.

Key facts

Extracted from this filing and checked against the source text.

Listing & Compliance Notices SEC 8-K Item 3.01 confidence 0.9

BioCardia, Inc. received a nasdaq extension granted notice regarding stockholders equity (rules 5550(b)(1)).

Exchange
nasdaq
Notice
extension granted
Deficiency
stockholders equity
Rules
5550(b)(1)
Exact text from the filing
June 9, 2026, received written notice that, based on review of the compliance plan, the Nasdaq staff granted the Company an extension to October 7, 2026 to regain compliance with the Rule. The Company is filing this Current Report on Form 8-K (this “Report”) to provide an update to its compliance with continued listing requirements as set forth in Nasdaq Listing Rule 5550(b)(1). On June 8, 2026, the Company filed an 8-K and issued a press release announcing that the Company sold 3,509,604 shares at an average price of $1.279 on Friday, June 5, 2026. The shares were sold pursuant to the Company
View on SEC.gov

95 listing & compliance notices filed in the last 30 days. Browse all listing & compliance notices →

BioCardia, Inc. filing history →

Source: SEC EDGAR
accession 0001437749-26-020384
Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.